Inhibikase Therapeutics, Inc.IKTNASDAQ
LOADING
|||
Net Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-27.52M
↓ 172% below average
Average (8y)
$-10.13M
Historical baseline
Range
High:$-436075.00
Low:$-27.52M
CAGR
+60.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-27.52M | -44.6% |
| 2023 | $-19.03M | -5.4% |
| 2022 | $-18.05M | -22.1% |
| 2021 | $-14.79M | -419.2% |
| 2020 | $-2.85M | +50.2% |
| 2019 | $-5.72M | -165.9% |
| 2018 | $-2.15M | -393.6% |
| 2017 | $-436075.00 | +30.6% |
| 2016 | $-628737.00 | - |